Your Article Summary
Human genome sciences to host july conference call to discuss top-line phase 3 results for benlysta (formerly lymphostat-b) in systemic lupus erythematosus
Human Genome Sciences, 07/02/09
Human Genome Sciences, Inc. announced that it expects to have top-line results available on Monday, July 20, from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA in systemic lupus erythematosus (SLE).
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09
AMA meeting: Nap time mandate for on-call residents rejected
American Medical News , 11/25/09
AMA meeting: Delegate vote refines AMA stance on system reform
American Medical News , 11/25/09
Article Search
Sponsor


See Latest Articles


